EMEIS Fundamental Analysis - EMEIS SA

Fundamental Rating

Overall EMEIS gets a fundamental rating of 1 out of 10. We evaluated EMEIS against 25 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of EMEIS have multiple concerns. EMEIS is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year EMEIS has reported negative net income.

In the past year EMEIS had a positive cash flow from operations.

In multiple years EMEIS reported negative net income over the last 5 years.

EMEIS had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

EMEIS's Return On Assets of -3.07% is on the low side compared to the rest of the industry. EMEIS is outperformed by 88.00% of its industry peers.

EMEIS has a Return On Equity of -23.89%. This is amonst the worse of the industry: EMEIS underperforms 88.00% of its industry peers.

The Return On Invested Capital of EMEIS (0.03%) is worse than 84.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-3.07%
ROE	-23.89%
ROIC	0.03%

ROA(3y)-7.04%

ROA(5y)-3.96%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 0.08%, EMEIS is doing worse than 84.00% of the companies in the same industry.

EMEIS's Operating Margin has declined in the last couple of years.

EMEIS does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	0.08%
PM (TTM)	N/A
GM	N/A

OM growth 3Y-79.31%

OM growth 5Y-64.56%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EMEIS is destroying value.

EMEIS has more shares outstanding than it did 1 year ago.

The number of shares outstanding for EMEIS has been reduced compared to 5 years ago.

The debt/assets ratio for EMEIS is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.60, we must say that EMEIS is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 0.60, EMEIS is doing worse than 76.00% of the companies in the same industry.

EMEIS has a debt to FCF ratio of 51.23. This is a negative value and a sign of low solvency as EMEIS would need 51.23 years to pay back of all of its debts.

EMEIS has a Debt to FCF ratio of 51.23. This is amonst the worse of the industry: EMEIS underperforms 88.00% of its industry peers.

EMEIS has a Debt/Equity ratio of 4.80. This is a high value indicating a heavy dependency on external financing.

With a Debt to Equity ratio value of 4.80, EMEIS is not doing good in the industry: 84.00% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	4.8
Debt/FCF	51.23
Altman-Z	0.6

ROIC/WACC0.01

WACC4.78%

2.3 Liquidity

EMEIS has a Current Ratio of 0.62. This is a bad value and indicates that EMEIS is not financially healthy enough and could expect problems in meeting its short term obligations.

EMEIS has a worse Current ratio (0.62) than 80.00% of its industry peers.

A Quick Ratio of 0.62 indicates that EMEIS may have some problems paying its short term obligations.

Looking at the Quick ratio, with a value of 0.62, EMEIS is doing worse than 68.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.62
Quick Ratio	0.62

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for EMEIS have decreased strongly by -142.36% in the last year.

Looking at the last year, EMEIS shows a quite strong growth in Revenue. The Revenue has grown by 8.43% in the last year.

The Revenue has been growing by 8.55% on average over the past years. This is quite good.

EPS 1Y (TTM)-142.36%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-114.25%

Revenue 1Y (TTM)8.43%

Revenue growth 3Y9.45%

Revenue growth 5Y8.55%

Sales Q2Q%7.73%

3.2 Future

Based on estimates for the next years, EMEIS will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.91% on average per year.

The Revenue is expected to grow by 2.70% on average over the next years.

EPS Next Y61.81%

EPS Next 2Y28.88%

EPS Next 3Y29.56%

EPS Next 5Y17.91%

Revenue Next Year5.29%

Revenue Next 2Y5.18%

Revenue Next 3Y5.22%

Revenue Next 5Y2.7%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EMEIS. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EMEIS. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, EMEIS is valued a bit cheaper than 68.00% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	10.04
EV/EBITDA	N/A

4.3 Compensation for Growth

EMEIS's earnings are expected to grow with 29.56% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y28.88%

EPS Next 3Y29.56%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for EMEIS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EMEIS SA

EPA:EMEIS (7/25/2025, 11:53:57 AM)

10.85

+0.34 (+3.24%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)05-13 2025-05-13

Earnings (Next)07-24 2025-07-24

Inst Owners55.54%

Inst Owner ChangeN/A

Ins Owners0%

Ins Owner ChangeN/A

Market Cap1.75B

Analysts75.38

Price Target12.34 (13.73%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)7.56%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.67%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.31
P/FCF	10.04
P/OCF	3.71
P/B	1.02
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-2.65

EYN/A

EPS(NY)-0.85

Fwd EYN/A

FCF(TTM)1.08

FCFY9.96%

OCF(TTM)2.92

OCFY26.95%

SpS34.91

BVpS10.68

TBVpS-7.69

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.07%
ROE	-23.89%
ROCE	0.04%
ROIC	0.03%
ROICexc	0.03%
ROICexgc	0.04%
OM	0.08%
PM (TTM)	N/A
GM	N/A
FCFM	3.1%

ROA(3y)-7.04%

ROA(5y)-3.96%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3Y-77.23%

ROICexcg growth 5Y-61.49%

ROICexc growth 3Y-76.08%

ROICexc growth 5Y-60.94%

OM growth 3Y-79.31%

OM growth 5Y-64.56%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.42

Health

		Industry Rank	Sector Rank
Debt/Equity	4.8
Debt/FCF	51.23
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	5.28%
Interest Coverage	250
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.62
Quick Ratio	0.62
Altman-Z	0.6

F-Score4

WACC4.78%

ROIC/WACC0.01

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)5.82%

Cap/Sales(5y)13.23%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-142.36%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-114.25%

EPS Next Y61.81%

EPS Next 2Y28.88%

EPS Next 3Y29.56%

EPS Next 5Y17.91%

Revenue 1Y (TTM)8.43%

Revenue growth 3Y9.45%

Revenue growth 5Y8.55%

Sales Q2Q%7.73%

Revenue Next Year5.29%

Revenue Next 2Y5.18%

Revenue Next 3Y5.22%

Revenue Next 5Y2.7%

EBIT growth 1Y103.51%

EBIT growth 3Y-77.35%

EBIT growth 5Y-61.53%

EBIT Next Year10863.7%

EBIT Next 3Y422.27%

EBIT Next 5Y253.99%

FCF growth 1Y293.3%

FCF growth 3YN/A

FCF growth 5Y14.58%

OCF growth 1Y28.92%

OCF growth 3Y-14.44%

OCF growth 5Y-10.16%

EMEIS SA (EMEIS.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens